Jersey Milk chocolate bars being discontinued amid low consumer demand
Send this page to someone via email
Share this item on Twitter
Share this item via WhatsApp
Share this item on Facebook
Mondelez Canada Inc. says it's no longer producing Jersey Milk chocolate bars.
Spokesperson Pierina De Carolis says the confectionary company's decision to cut the product came after a portfolio review showed consumers have shifted to buying other pure milk chocolate bars like Cadbury Dairy Milk.
Get daily National news
Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
De Carolis says in an email that Jersey Milk was only produced in Canada.
She adds the end of its production will not result in any job cuts.
Jersey Milk dates back to 1924, when it was developed by Canadian dairy brand William Neilson Ltd.
A series of acquisitions left the bar under the purview of Mondelez International, which has a downtown Toronto Cadbury chocolate factory, employing nearly 400 workers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Vancouver Sun
an hour ago
- Vancouver Sun
Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
WASHINGTON — Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. 'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India. A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month. Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said. Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said. He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal. 'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said. But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country. Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market. Drugmakers have said that tariffs on pharmaceuticals could also cause shortages in the United States and increase costs for Americans who need medicine. 'I think as a Canadian industry and as part of a global industry, we've been operating without tariffs for the last several decades and imposing tariffs is going to increase costs and complicate supply chains,' Keon said. Keon said there is support for the Trump administration launching separate studies looking for ways to reduce prices and make the U.S. a more attractive market for drug manufacturing. Certain measures like harmonizing regulatory standards with those of other countries would help reduce unnecessary costs, he said. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Edmonton Journal
an hour ago
- Edmonton Journal
Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
Drugmakers say that tariffs on pharmaceuticals could cause shortages in the U.S. and increase costs for Americans who need medicine. Photo by WilliamWASHINGTON — Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Exclusive articles by David Staples, Keith Gerein and others, Oilers news from Cult of Hockey, Ask EJ Anything features, the Noon News Roundup and Under the Dome newsletters. Unlimited online access to Edmonton Journal and 15 news sites with one account. Edmonton Journal ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Exclusive articles by David Staples, Keith Gerein and others, Oilers news from Cult of Hockey, Ask EJ Anything features, the Noon News Roundup and Under the Dome newsletters. Unlimited online access to Edmonton Journal and 15 news sites with one account. Edmonton Journal ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors 'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Get the latest headlines, breaking news and columns. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India. A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month. Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said. Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said. He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal. 'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said. But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country. Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market.
Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
Manitoba exports to U.S., China plummet
While Manitoba's exports to the United States and China plunged earlier this year, the dollar value of its imports soared. U.S. imports to Manitoba hit roughly $10.97 billion in January through May — an eight per cent increase from the same time in 2024. Meanwhile, imports from China jumped 6.9 per cent year-over-year, totalling $684 million. 'It's surprising,' said Chuck Davidson, president of the Manitoba Chambers of Commerce. Tim Smith/The Brandon Sun Files Canola and corn grow south of Rivers on Tuesday. Canola oil and meal have been slapped with massive import tariffs by the Chinese government, leading to a downturn in trade. He's tracked a sentiment across businesses to bring their supply chains closer to home. Uncertainty has rocked the private sector since Donald Trump was elected U.S. president in November. Tariffs and tariff threats have made regular headlines, shaking operations and causing companies to pause future investments. Davidson pointed to a weaker Canadian dollar: some companies can't get materials they require within Canada and must pull from the United States. Those goods are likely more expensive, he surmised. A Canadian dollar equated to US$0.73 on Wednesday. The exchange rate began increasing last fall, ahead of the U.S. election. Companies also bulk bought in preparation for tariffs, noted Fletcher Baragar, a University of Manitoba economics professor. The rush could've shown in the January through May import numbers, recently released by the Manitoba Bureau of Statistics. Manitoba's exports to the U.S. dropped 14.7 per cent year-over-year; they fell 29.8 per cent when looking at China. The export values totalled $5.55 billion and $481 million, respectively. Davidson cited the 'Trump factor' for the U.S. decrease. The Trump administration has placed tariffs on aluminum, steel and items not meeting the Canada-United States-Mexico Agreement on trade. Globally, countries have been slapped with U.S. tariffs. It's affected businesses like Kathy Tran-Riese's. Tran-Riese opted to pause sales in the U.S., starting in May, to avoid the cost of her glasses frames more than doubling. KayTran Eyewear imports frames to Winnipeg from China before exporting to the United States. The U.S. deems the goods Chinese by their country of origin; Trump stripped China of an exemption where packages under $800 were shielded from tariffs. 'I had a pretty large consumer base in the U.S.,' Tran-Riese said Wednesday. Roughly half of her revenue came from the southern clientele. However, since halting shipments to the U.S., she's seen an 80 per cent jump in sales: she's been holding pop-ups across Canada. '(There's) an initial myth that you think you have to … have a stronghold in the U.S. to build good revenue,' said Tran-Riese, who had Canadian customers asking for pop-ups before Trump's inauguration. 'This has really taught me otherwise.' Boosting interprovincial trade will help lessen reliance on United States exports, Davidson said. So will increasing trade to other countries, both he and Baragar relayed. Manitoba's non-U.S. exports jumped 6.5 per cent year over year, when comparing January through May. The total reached $2.55 billion. Non-U.S. imports rose at a faster pace — up 10.3 per cent, to $3.65 billion. 'I suspect we'll probably see more of that in the future, but those numbers are proportionately very, very small,' Baragar said. 'There's enormous potential for growth, but Canada — certainly for the last 50 years — hasn't really been looking in those directions.' Nineteen European delegates visited Manitoba in April, expressing a desire for more trade. Africa and other Pacific Rim countries are also candidates for future growth, from Baragar's view. Chinese tariffs remain in place. Cam Dahl, general manager of Manitoba Pork, said he's 'not surprised' by the statistic of fewer exports. China placed tariffs of 100 per cent on Canadian canola oil, canola meal and peas, and of 25 per cent on some pork, fish and seafood. The measures came as retaliation to Canadian tariffs on Chinese electric vehicle imports. Dahl is meeting with Canadian, American and Mexican counterparts later this week to discuss trade, among other topics. 'It just shows — the understanding of the value of that integrated market isn't just in Canada, it goes across North America,' he said. 'There's just so much uncertainty.' Prime Minister Mark Carney has circled July 21 as a Canada-U.S. deal deadline. The outcome will shape Manitoba's import and export numbers for the rest of the year, Baragar forecast. British Columbia, Alberta, Saskatchewan, Quebec, New Brunswick and Nova Scotia joined Manitoba in experiencing a year-over-year decrease in international merchandise exports in May. (Manitoba's drop was the largest, at 19 per cent.) Energy, forestry and industrial equipment exports plunged that month, Statistics Canada data shared publicly by the Saskatchewan government show. Monday Mornings The latest local business news and a lookahead to the coming week. Generally, Manitoba exports decreased nine per cent — to $8.11 billion — when comparing 2025's first five months to 2024's. Imports jumped 8.5 per cent, to $14.62 billion. Manitoba trucking firms have been shuttering and laying off staff due to less demand, the Manitoba Trucking Association confirmed last week. The provincial government is increasing its export support program and passed the Fair Trade in Canada Act to promote trade within Canada and abroad, Business Minister Jamie Moses said in a statement. The New Democrats hired Richard Madan, a former reporter, to become Manitoba's trade representative to the U.S. Gabrielle PichéReporter Gabrielle Piché reports on business for the Free Press. She interned at the Free Press and worked for its sister outlet, Canstar Community News, before entering the business beat in 2021. Read more about Gabrielle. Every piece of reporting Gabrielle produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
